Kinloch Capital Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Consumer Discretionary ETF
VCR
|
+$7.78M |
| 2 |
Clorox
CLX
|
+$2.66M |
| 3 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$1.5M |
| 4 |
AbbVie
ABBV
|
+$852K |
| 5 |
Cardinal Health
CAH
|
+$816K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Health Care ETF
VHT
|
+$6.79M |
| 2 |
AT&T
T
|
+$1.96M |
| 3 |
Vanguard Information Technology ETF
VGT
|
+$1.64M |
| 4 |
Nucor
NUE
|
+$1.54M |
| 5 |
Target
TGT
|
+$1.06M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 19.58% |
| 2 | Healthcare | 9.93% |
| 3 | Industrials | 8.9% |
| 4 | Financials | 8.65% |
| 5 | Consumer Discretionary | 6.2% |
Similar funds
Kinloch Capital's Q4 2021 Portfolio in Review
As of Q4 2021, Kinloch Capital held 68 positions worth $161M, up 14% from $142M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Kinloch Capital deployed $7.99M of net new capital in Q4 2021, opening 7 new positions and adding to 32 existing holdings. Its largest new stake was Vanguard Consumer Discretionary ETF: 23,176 shares worth $7.89M.
By sector, the portfolio is most concentrated in Consumer Staples at 20% of assets, up from 18% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Vanguard Information Technology ETF, an estimated $1.64M trimmed.
- Kinloch Capital's largest Q4 2021 buy was Vanguard Consumer Discretionary ETF: 23,176 shares worth $7.89M.
- Kinloch Capital added most to JPMorgan Ultra-Short Income ETF in Q4 2021, an estimated $1.5M increase.
- Kinloch Capital's biggest Q4 2021 reduction was Vanguard Information Technology ETF, cutting an estimated $1.64M.
- Kinloch Capital fully exited Vanguard Health Care ETF in Q4 2021, selling an estimated $6.79M.
- Kinloch Capital's ten largest holdings make up 36% of its $161M portfolio in Q4 2021.
- Kinloch Capital opened 7 new positions and closed 2 in Q4 2021.
- Kinloch Capital's portfolio value rose 14% quarter-over-quarter to $161M.
Based on Kinloch Capital's 13F filing for Q4 2021, filed 20 Jan 2022.